Statins have no role in pulmonary disease mortality.

1 Frost FJ, Petersen H, Tollestrup K, et al. Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. Chest 2007; 131:1006–1012 2 Suissa S. Effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease: immortal time bias in observational studies. Am J Respir Crit Care Med 2003; 168:49–53 3 Majumdar SR, McAlister FA, Eurich DT, et al. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006; 333:999–1003 4 Thomsen RW. The lesser known effects of statins: benefits on infectious outcomes may be explained by “healthy user” effect. BMJ 2006; 333:980 –981

[1]  B. Skipper,et al.  Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins. , 2007, Chest.

[2]  G. Mancini.  Clarion call for trials assessing "cardiopulmonary" agents to reduce morbidity and mortality in inflammatory lung diseases. , 2007, Chest.

[3]  F. McAlister,et al.  Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study , 2006, BMJ : British Medical Journal.

[4]  John R Hurst,et al.  Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[5]  N. Thomson,et al.  Potential therapeutic role for statins in respiratory disease , 2006, Thorax.

[6]  H. Concin,et al.  Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality. , 2004, Journal of women's health.

[7]  Y. Matsuzawa,et al.  Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[8]  AndrewJ. S. Coats.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.

[9]  S. Yusuf.  MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .

[10]  D. Jacobs,et al.  Serum total cholesterol and risk of hospitalization, and death from respiratory disease. , 1997, International journal of epidemiology.